Dr. Jan Berger is a tri-sector healthcare executive with proven results in private, public and government services over the last 30 years. In 2009, Jan founded Health Intelligence Partners, a global health care consultancy. She previously served as Senior Vice President, Chief Clinical Officer and Innovation Officer for CVS Health/Caremark, and is an assistant professor at Northwestern University School of Medicine and School of Communication. Jan is Chair-Elect of Medecision's Advisory Board, and sits on the boards of Cambia Health Solutions, GNS Healthcare, Tabula Rasa, Accent Care, UCB Pharmaceuticals and Voluntis Health Care.
Dr. Jan Berger is a tri-sector healthcare executive with a background in public, private and government sectors. In 2009, she helped found Health Intelligence Partners, a global healthcare consultancy. Below, Dr. Berger shares her thoughts on how healthcare will change after COVID-19.
In this episode, Medecision Advisory Board chair-elect Dr. Jan Berger gives us some thought-provoking perspectives around what population health looks like during, as well as after, the COVID-19 pandemic, and what that may mean for the healthcare system.
